A Phase III, Multicenter, Open-Label, Dose-Titrating, 16-Week Study Evaluating The Efficacy, Tolerability and Safety of Olmesartan Medoxomil 20 Mg and 40 Mg Alone or in Combination With 12.5 Mg to 25 Mg of Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
A Phase III, Multicenter, Open-Label, Dose-Titrating, 16-Week Study Evaluating The Efficacy, Tolerability and Safety of Olmesartan Medoxomil 20 Mg and 40 Mg Alone or in Combination With 12.5 Mg to 25 Mg of Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
Efficacy, tolerability and safety of olmesartan alone or in combination with hydrochlorothiazide in the treatment of mild to moderate essential hypertension
Inclusion Criteria:
Exclusion Criteria:
Cartagena, Atlántico, Colombia
Bogota, Cundinamarca, Colombia
Escobedo, Guayas, Ecuador
NT, Hong Kong
Guei-Shan Shiang, Tau-Yuan Shian 333, Taiwan
Khet Rajathevee, Bangkok 10400, Thailand
Bornova/Izmir, 35100, Turkey (Türkiye)
Haseki/Istanbul, 34390, Turkey (Türkiye)
S¿hhiye/Ankara, 06100, Turkey (Türkiye)
Sihhiye/Ankara, 06100, Turkey (Türkiye)